Pharma Rebrands More Often and Gets Better Results

When Actavis acquired Forest Labs in 2014 it chose to rebrand the products under its own, better known name. That rebranding decision helped Actavis expand the reach of Forest Labs’ products, especially those in women’s health and gastroenterology.

That example is one of the most successful merger rebrandings in a study from the brand valuation consultancy, Brand Finance.

Researching the results of 3,000 mergers and acquisitions since 2014, Brand Finance found 21% resulted in a rebranding, typically of the acquired company’s products. Of all the industries, pharma was the most prolific – and financially successful – in rebranding.

The report says pharmaceutical companies rebranding 31% of the acquired companies. Most of the time the rebranding decision was made because the acquiring company had the stronger name. Sometimes, as when Eli Lilly acquired Novartis Animal Health, it was to avoid brand confusion.

Alex Haigh, Brand Finance valuation director, told FiercePharma, “Pharmaceutical companies tend to be very experienced in mergers and acquisitions. Of the eight companies with the most rebranded acquisitions, three are pharmaceutical companies — Allergan, Lilly and Roche.

“Companies which are experienced in integrating acquisitions tend to be more likely to rebrand and have better results.”

Compared to M&A rebrandings in other sectors, pharma’s are significantly better. The report found pharma had a first year return of 13.8%. Only telecoms and the tech sector had positive first year returns on their rebrandings.

“The success of rebranding strongly depends on sector,” the report observes. “For example, in pharmaceuticals, where acquisitions generally have not built strong brands but acquirers have, rebrands are highly successful.”

“Superior marketing and client networks of the larger players lend themselves to the trend to rebrand for this reason. Also, since there are often positive reputational benefits from new drug development, rebranding can help wider business performance through association.”

Illustrating this point, the Brand Finance reports points to Roche, citing the big pharma firm for its “flexible rebranding strategy.” Roche rebranded its acquisition of three smaller firms — Ignyta, Intermune and Seragon.

But Roche retained the separate brands Flatiron, a medical technology company, and the molecular insights company Foundation Medicine because each already had an established client base and strong name recognition.

Actavis itself is a rebranding poster child. A year after completing the acquisition of Forest Labs, Actavis bought Allergan adopting the name of the acquired company, rolling it out slowly and geographically.

Last month, AbbVie completed its $63 billion acquisition of Allergan and retired the name.

Photo by Stephen Foster on Unsplash

Best Practices for Performance Reviews
General Interest

Best Practices for Performance Reviews

Cultural Sensitivity in the Workplace
General Interest

Cultural Sensitivity in the Workplace

#WeAreGreenKey: Spotlight on Tim Coonan
Architecture + Engineering General Interest

#WeAreGreenKey: Spotlight on Tim Coonan

Green Key Unlocked: Soft Skills Recruiters Should Have in the Age of AI
General Interest

Green Key Unlocked: Soft Skills Recruiters Should Have in the Age of AI

The Power of Feedback in The Workplace
General Interest

The Power of Feedback in The Workplace

#WeAreGreenKey: Spotlight on Ariana Ali
General Interest Worklife

#WeAreGreenKey: Spotlight on Ariana Ali

Green Key Named Best Executive Search Firm in Hedgeweek Awards
Accounting + Finance General Interest

Green Key Named Best Executive Search Firm in Hedgeweek Awards

LinkedIn Reaches 1B Users and Launches New AI Tools
General Interest

LinkedIn Reaches 1B Users and Launches New AI Tools

The Soft Skills Tech Talent Need
General Interest Information Technology

The Soft Skills Tech Talent Need

Upskilling: Your Path to Personal and Professional Growth
General Interest

Upskilling: Your Path to Personal and Professional Growth

#WeAreGreenKey: Spotlight on Trisha Hankins
General Interest Healthcare

#WeAreGreenKey: Spotlight on Trisha Hankins

Green Key Unlocked: Navigating a Career Transition to Analytics
General Interest Information Technology

Green Key Unlocked: Navigating a Career Transition to Analytics

Team Dynamics Deciphered: A Guide to Finding Your Place as a New Member
General Interest Worklife

Team Dynamics Deciphered: A Guide to Finding Your Place as a New Member

#WeAreGreenKey: Spotlight on Krista Zielinski
General Interest Pharma

#WeAreGreenKey: Spotlight on Krista Zielinski

We Stand with Israel
General Interest

We Stand with Israel

Time Blindness: Impact and Management
General Interest Human Resources

Time Blindness: Impact and Management

Things You Shouldn’t Say During the Salary Negotiation Process
General Interest Human Resources Professional Support Worklife

Things You Shouldn’t Say During the Salary Negotiation Process

Salary Negotiations: Strategize Your Worth
General Interest Human Resources Professional Support

Salary Negotiations: Strategize Your Worth

#WeAreGreenKey: Spotlight on Brad Martin
Architecture + Engineering General Interest

#WeAreGreenKey: Spotlight on Brad Martin

Green Key Unlocked: Mastering your Healthcare Interview
General Interest Healthcare

Green Key Unlocked: Mastering your Healthcare Interview

Latest Blog Posts
View All Posts
Best Practices for Performance Reviews

Best Practices for Performance Reviews

Performance reviews, often met with anxiety and anticipation, are an integral part to a thriving workplace and the cornerstone of...
Read More
Cultural Sensitivity in the Workplace

Cultural Sensitivity in the Workplace

Cultural sensitivity is a pivotal factor in creating a workplace where every individual can flourish.
Read More
#WeAreGreenKey: Spotlight on Tim Coonan

#WeAreGreenKey: Spotlight on Tim Coonan

Tim started his recruiting career almost five years ago when he transitioned from an accounting and sports marketing career.
Read More